san 58035 has been researched along with 24,25-epoxycholesterol in 1 studies
| Studies (san 58035) | Trials (san 58035) | Recent Studies (post-2010) (san 58035) | Studies (24,25-epoxycholesterol) | Trials (24,25-epoxycholesterol) | Recent Studies (post-2010) (24,25-epoxycholesterol) |
|---|---|---|---|---|---|
| 58 | 1 | 12 | 65 | 0 | 18 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Endo, K; Fukunaga, M; Gon, Y; Hashimoto, S; Hashimoto, Y; Makishima, M; Nishida, S; Nunomura, S; Okayama, Y; Ra, C | 1 |
1 other study(ies) available for san 58035 and 24,25-epoxycholesterol
| Article | Year |
|---|---|
Mast cell death induced by 24(S),25-epoxycholesterol.
Topics: Amides; Animals; Caspase 3; Caspase 7; Caspase Inhibitors; Cell Death; Cells, Cultured; Cholesterol; Cytoprotection; DNA Fragmentation; Enzyme Activation; Lipid Metabolism; Liver X Receptors; Mast Cells; Mevalonic Acid; Mice; Mice, Inbred C57BL; Organosilicon Compounds; Orphan Nuclear Receptors; Protease Inhibitors; Sterol O-Acyltransferase | 2010 |